Skip to Main Content

Paper Details

Patient and provider perspectives on polygenic risk scores: implications for clinical reporting and utilization.
Genome Med
13
2022
Author NameAffiliation
Anna C F LewisE.J. Safra Center for Ethics, Harvard University
Anna C F LewisBrigham and Women's Hospital
Anya E R PrinceCollege of Law, University of Iowa
Paulette D ChandlerBrigham and Women's Hospital
Matthew S Lebo
Matthew S LeboBrigham and Women's Hospital
Matthew S LeboHarvard Medical School
Matthew S LeboBroad Institute of MIT and Harvard
Jordan W SmollerCenter for Genomic Medicine, Massachusetts General Hospital
Jordan W SmollerStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard
Jordan W SmollerCenter for Precision Psychiatry, Massachusetts General Hospital
Jordan W SmollerCenter for Genomic Medicine, Massachusetts General Hospital
Jordan W SmollerCenter for Precision Psychiatry, Massachusetts General Hospital
Jordan W SmollerStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard
Scott T WeissBrigham and Women's Hospital
Scott T Weiss
Scott T WeissBrigham and Women's Hospital
Scott T Weiss
James B MeigsHarvard Medical School
James B MeigsMassachusetts General Hospital
James B MeigsBroad Institute of MIT and Harvard
Robert C GreenBrigham and Women's Hospital
Robert C GreenHarvard Medical School
Robert C GreenBroad Institute of MIT and Harvard
Robert C Green
Robert C Green
Elizabeth W KarlsonBrigham and Women's Hospital
Elizabeth W Karlson
Elizabeth W KarlsonHarvard Medical School
Elizabeth W KarlsonBrigham and Women's Hospital
Elizabeth W Karlson
Elizabeth W KarlsonHarvard Medical School
  • 1 - 32

Datasets